The Saudi Food and Drug Authority (SFDA) has introduced strict regulations for pilgrims bringing narcotic drugs and psychotropic medications into Saudi Arabia, outlining permit requirements, documentation, and quantity limits to ensure safety during Hajj and Umrah.
SFDA Regulations for Pilgrims’ Medications
The SFDA clarified that pilgrims carrying medications containing narcotic drugs or psychotropic substances must obtain a clearance permit before entering the Kingdom.
To apply for the permit, applicants must submit several documents, including:
Required Documents for Medication Permit
- A copy of the pilgrim’s passport
- A valid medical prescription or report issued within the last six months
- A clear photo of the medication and its outer packaging
Applicants are also required to agree to an electronic declaration before submitting their application through the system.
Limit on Medication Quantity
The SFDA emphasized that the permitted quantity of narcotic or psychotropic medications must not exceed a 30-day supply or the duration of the pilgrim’s stay in Saudi Arabia, whichever is shorter.
This limit is determined based on the dosage specified in the medical prescription or report submitted during the application process.
How to Apply Through CDS System
Pilgrims can apply for medication clearance permits by creating a “Personal Traveler Account” through the Electronic Controlled Drugs System (CDS).
This digital system streamlines the approval process and ensures compliance with Saudi Arabia’s healthcare and drug safety regulations.
Ensuring Safety and Smooth Pilgrim Experience
These regulations are part of SFDA’s broader efforts to provide a safe and seamless experience for pilgrims visiting the Holy Sites.
The authority aims to facilitate religious rituals while ensuring the health and safety of all visitors by regulating controlled medications effectively.
SFDA Continues to Strengthen Drug Control Measures
The SFDA reaffirmed its commitment to monitoring and regulating the entry of controlled medications into Saudi Arabia.
These measures help prevent misuse, ensure compliance with international drug control standards, and protect public health during the Hajj season.








